Skip to content

Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients

Sep 2026 · Cancer Chemotherapy and Pharmacology · Vol 96 · 0 citations · 26 references
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.